Issue The Future of Healthcare

Current Issue: Q4 2020

The Innovation Issue

The Future of Healthcare

Our fourth quarter edition features leading insights from subject matter experts covering a range of topics, with a focus on innovations driving the future of healthcare, including solutions to the COVID-19 pandemic. In this issue, leaders from all facets of the pharmaceutical industry discuss their approach to developing and distributing COVID-19 vaccines globally, enabling innovation, facilitating decentralized clinical trials, stem cell technology, and ways to communicate and conduct marketing virtually during the pandemic.

Also In This Issue

Cover Story

Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma

In these unprecedented times, we are deeply committed to safeguarding the reliable delivery of essential therapeutics for our clients while also remaining dedicated to ensuring the safety of our employees and partners. The continuous optimization of operational fitness has always been an integral part of our strategy. In alignment with local health authorities and with […]

Nice Insight Overview

Delivering Vaccines During a Pandemic

NICE INSIGHT OVERVIEW: Vaccine Distribution Developing potential COVID-19 vaccines at an accelerated pace has been a tremendous challenge. Looking forward, the world faces another monumental task: administering those vaccines — once approved — to billions. The Ultimate Supply Chain Challenge As of October 7, 2020, more than 35.5 million confirmed cases of COVID-19, including more […]

Single-Use Technology

Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT

Avid Bioservices began transitioning to single-use technology (SUT) several years ago and has reaped considerable benefits, both to our operations and to the agile service we provide customers. Saying Goodbye to Stainless Steel Stainless steel facilities are on their way out. With the high titers obtained today, 2000-L single-use (SU) bioreactors are sufficient for most […]

Industry Leader

Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing

As a leading CDMO focused on biopharmaceuticals in an increasingly complex global landscape, Rentschler Biopharma SE continues to strategically innovate through a unique go-to-market approach that is as flexible as it is nuanced. Sustainability and value creation are central focal points of the company’s “Strategy 2025” initiative, a forward-looking vision that was created by gathering […]

Clinical Trials

Modern Strategies for Dermatology Clinical Trials

To be most successful, dermatology clinical trials should be accessible to a diverse array of qualified patients and designed to encourage patient participation. These trials should also reduce the patient and investigator site burdens, reduce start-up and enrollment timelines, and ensure consistent, high-quality assessments and data collection. With extensive experience in dermatology trials; an international […]

Hot Melt Extrusion

Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion

IN CONVERSATION: Daniel Price and Thomas Kipping, Ph.D., discussed MilliporeSigma’s contribution to overcoming solubility challenges with Pharma’s Almanac Scientific Editor-in-Chief David Alvaro. Hot melt extrusion (HME) is an attractive method for the generation of amorphous solid dispersions of poorly soluble APIs. Polyvinyl alcohol has recently attracted attention for HME due to its unique behavior under higher shear forces and its […]

COVID-19 vaccine

How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Partnerships

The COVID-19 pandemic has stretched the limits of pharmaceutical development and manufacturing due to the pressing need for billions of doses to reach patients as soon as possible. It is clear that broad social change, science-driven development, and strong partnerships will be required to combat this public health crisis in the near term, but there […]

Digital Transformation

Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients

There is tremendous opportunity to elevate customer experiences and enhance internal operations through digital transformation. At PCI Pharma Services, we embarked on a digital transformation two years ago and most recently, we launched our pci | bridge platform, which is helping customers manage their clinical and commercial programs more efficiently by providing real-time data access […]

Personalized Medicines

Disruptive Technologies in Life Sciences: Personalized Medicines

Personalized treatments are poised to have a tremendous positive impact for patients across disease indications. However, a number of challenges to the discovery, development, manufacture, and administration of these novel therapies remain unresolved. Corning Life Sciences — through its many optimized products for organoid growth and creative tools and technologies for simplifying workflows, such as […]

Corporate Social Responsibility

Life Imitating Science: Arranta Bio’s Commitment to Corporate Social Responsibility and Diversity

As a pioneering CDMO innovating solutions in supplying live biotherapeutics, Arranta Bio is at the forefront of some of the most exciting advances in the microbiome space. Since the inception of the human microbiome project in 2007, the number of academic publications and active patent families around the microbiome has grown exponentially.1 Problems within the […]

Past Issues

View all Past Issues

The Advanced Therapeutics Issue

View Issue »

Issue #2 | Volume #5 | Q2 2019

The Growing Role of Innovative Technologies

View Issue »

Issue #1 | Volume #1 | Q4 2015

The Outsourcing Issue

View Issue »

Issue #3 | Volume #6 | Q3 2020

The Role of Innovative Technologies

View Issue »

Issue #4 | Volume #2 | Q4 2016